Association of total and bioactive serum sclerostin levels with bone metabolism in type 2 diabetes mellitus

Background: Sclerostin has been associated with decreased bone turnover in patients with type 2 diabetes mellitus (T2DM). The relationship with bone turnover markers (BTMs) and bone mineral density (BMD) remains unclear. We investigate the relationship between total and bioactive sclerostin measured...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Cyril Traechslin, Lilian Sewing, Sandra Baumann, Leticia Grize, Janina Vavanikunnel, Marius Kraenzlin, Christoph Henzen, Christian Meier
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Elsevier 2025-06-01
Edice:	Journal of Clinical & Translational Endocrinology
Témata:	Sclerostin Bioactive sclerostin Type 2 diabetes mellitus Osteoporosis Bone metabolism
On-line přístup:	http://www.sciencedirect.com/science/article/pii/S2214623725000110
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!